Free preview
MD Pharmacology NMC syllabus ~5 min read Recent advances last updated on 2026-05-28

Phenytoin

Prototype Na⁺-channel-blocking antiepileptic — mechanism, non-linear kinetics, adverse effects & status epilepticus

Past DNB + MPMSU · 4 MPMSUJan '25 MPMSUJun '23 DNBDec '22 MPMSU2005

Introduction

  • Phenytoin — 5,5-diphenylhydantoin — a five-membered hydantoin ring with two phenyl groups on C5; a barbiturate analogue but with a 5-membered (not 6-membered) ring.
  • Historical landmark — anticonvulsant activity discovered by Merritt & Putnam in 1938 using the maximal-electroshock seizure model — the first non-sedating anticonvulsant, abolishing the tonic phase of MES without general CNS depression.
  • Current place — the oldest non-sedating AED still in routine use; displaced as chronic first-line by carbamazepine, valproate, lamotrigine and levetiracetam (ADR + interaction burden) but remains indispensable for status epilepticus and in low-resource settings.
  • Indian context — Eptoin, Dilantin, Epsolin, Fentoin-ER — widely prescribed; 100 mg capsule ≈ ₹2; oral suspension and IV forms routinely stocked; retained in WHO mhGAP core AEDs for LMICs.
Continue reading

Phenytoin

PharmaNotes Pro · LAQ

Sign in with your Google account. If you're already subscribed, the chapter unlocks immediately — otherwise, pick Monthly or Annual on the next step.